Clinical ink, a global life science technology company, today announced that experienced healthcare industry veteran Dr. Jonathan Goldman MD has joined the company as Chief Executive Officer (CEO). Jonathan succeeds Ed Seguine who has led Clinical ink since nearly fourteen years ago.
Nature Magazine Publishes Work Demonstrating Clinical ink Technology Sensitivity to Parkinson’s Disease
COA vs. eCOA Cost Calculator
Get your study-specific cost comparison between paper COA and eCOA within 48 hours. See how much you can save today.
Breakthrough Evidence with Digital Biomarkers in Movement Disorders
See how we successfully demonstrated disease status and treatment response for clinical development and medical practice.
Collect data
as it happens,
from any source.
Click to explore our eSource tool to power faster, higher quality data.
Deloitte Technology Fast 500™
2021 and 2022 Award Recipient for Fastest-Growing Companies in North America.
Digital Biomarkers
Robust, scalable, innovative, proven analytics driven by patient-centric research.
Clinical ink is leading the way to recenter decentralized clinical trials by connecting data and operations.
At the core of our clinical trial solutions is the Clinical ink eSource ecosystem, designed to ingest all incoming data into a unified data platform that supports analytics within and across studies, regardless of how it was captured or by whom.
A Better eSource Solution
Clinical ink’s eSource methods integrate Direct Data Capture (DDC) technology and electronic Clinical Outcome Assessments (eCOA) for a wide range of phases and therapeutic areas.
The result is faster, higher-quality clinical trial data. Our eSource solutions ingest data from multiple sources, facilitating decentralized trials and shifting the industry towards capturing data directly from the patient.
0
+
Studies
0
+
Assessments
and Instruments
and Instruments
0
+
BYOD Studies
1
M+
Cognitive and Behavioral Measures
0
+
Sponsors and CROs
eSource Technology and Solutions
DDC Technology
Capture directly and validate data, documents, audio, images, and video in real time.
eCOA
Minimize complexity, accelerate study build, and cover therapeutic areas via fit-for-purpose assessments.
eConsent
Simplify and speed study startup, standardize processes, and empower patients.
Televisit
Deliver an easy, efficient, holistic telehealth solution and improve remote monitoring.
Mobile Devices
Deliver reach, efficiency, and data quality, while increasing patient engagement.
Sensors & Wearables
Enrich advanced clinical trial data collection with a variety of sensors and wearables solutions.
Digital Biomarkers
Validate measurements from sensors, algorithms, and deliver clinical data in real-time.
Patient Engagement
Optimize recruitment, engagement, and retention.
See everything our eSource technology platform has to offer.
eSource technologies improve the efficiency and reduce the cost of clinical trials, particularly in the context of complex therapeutic areas.Â
The depth and breadth of our therapeutic experience – across neurology, infectious disease, immunology, and oncology – means you get the expertise and improved results for your clinical research.Â
Neurology
Improve results for complex clinical trials involving central nervous system conditions.
Infectious Disease
Speed up trial timelines and improve the data quality of your infectious disease studies.
Immunology
Leverage eSource tools to simplify and improve outcomes in complex Lupus clinical trials.
Oncology
Deliver on the Enhancing Oncology Model and improve patient adherence throughout the trial.
